Prognosis of Heart Transplanted Patients With Heart Failure (RE-START)

Xi'an Jiaotong University

Status: Enrolling

Conditions: Heart Failure

Treatments: Procedure: Heart Transplant

Study type: Observational

Funder types: Other

Identifiers

NCT05775432

XJTU1AF2023LSK-391

Details and patient eligibility

About

Heart transplantation is the most effective treatment for end-stage heart failure, advanced cardiomyopathy, and complex congenital heart disease with severe heart failure or hypoxia. Several clinical studies have shown significant differences in the prognosis of heart transplantation patients with different etiologies, and post-transplantation complications are an important factor affecting patient survival, and there is still a lack of overall prognostic stratification and extensive clinical studies on risk factors after heart transplantation. Therefore, this study is intended to include patients who underwent heart transplantation for different etiologies of heart failure, collect clinical data and biological samples from patients, and use various techniques to deeply interpret the risk factors affecting the prognosis of heart transplantation patients and construct a prognostic prediction model to provide specific and individualized treatment ideas and theoretical basis for improving the survival rate of patients after heart transplantation.

Enrollment: 1,000 estimated patients

Sex: All

Ages: 3 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with end-stage heart failure presented to our hospital who are evaluated by clinicians and ethically approved for heart transplantation
• Individuals whose hearts are donated

Exclusion criteria

• Patients refuse to sign informed consent form

Trial design

1,000 participants in 2 patient groups

Heart transplantation group

Description:

Patients with heart failure of different etiologies undergoing heart transplant.

Control group

Description:

Individuals whose hearts are donated.